Qvist
Göran Qvist, Kungsor SE
Patent application number | Description | Published |
---|---|---|
20130283765 | INSERT, HOLDER AND POST-TREATMENT UNIT FOR EXHAUST GASES - An insert ( | 10-31-2013 |
Göran Qvist, Kungsor SE
Patent application number | Description | Published |
---|---|---|
20130283765 | INSERT, HOLDER AND POST-TREATMENT UNIT FOR EXHAUST GASES - An insert ( | 10-31-2013 |
Hans-Gunnar Qvist, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20090025915 | HEAT EXCHANGER FOR EGR-GAS - A heat exchanger for a first and a second medium flow includes flat tubes which have internal fins formed from zigzag-shaped sheet metal plate. The tubes have a thermally conductive connection to at least one duct for the one medium flow. Each fin is fixed only to the one longitudinal side of each tube. Furthermore, there is a gap between the fins fixed to the one longitudinal side and the opposite longitudinal side of the tube. | 01-29-2009 |
Ingmar Qvist, Northampton GB
Patent application number | Description | Published |
---|---|---|
20110081448 | PROCESS FOR TREATING VANILLA BEANS - There is provided a process for the preparation of cured vanilla bean pieces comprising steps of: i) blanching vanilla beans; ii) optionally cooling the blanched vanilla beans of step i); iii) comminuting the blanched vanilla beans of steps i) or ii); iv) incubating the comminuted pieces of step iii); and v) drying the incubated pieces of step iv). | 04-07-2011 |
Karsten Bruun Qvist, Frederiksberg C DK
Patent application number | Description | Published |
---|---|---|
20120021093 | METHOD FOR PRODUCING AN ACIDIFIED MILK PRODUCT - The present invention relates to a method for producing an acidified milk product using an enzyme having transglutammase activity. | 01-26-2012 |
20120045546 | METHOD FOR PRODUCING AN ACIDIFIED MILK PRODUCT - The present, invention relates to a method for producing an acidified milk product using an enzyme having transglutaminase activity, and fermenting the milk substrate with a microorganism which produces a polysaccharide, such as an exopolysaccharide (EPS). The present invention also relates to decreasing the ropyness of an acidified milk product and improving its texture. | 02-23-2012 |
20150030722 | METHOD FOR PRODUCING AN ACIDIFIED MILK PRODUCT - The present invention relates to a method for producing an acidified milk product using an enzyme having transglutaminase activity. | 01-29-2015 |
Karsten Bruun Qvist, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20130251848 | USE OF GLYCOSIDASE IN PREPARATION OF A MILK PRODUCT - A method for making a milk product (e.g. a yogurt) comprising adding an effective amount of an N-linked glycosidase and/or an O-linked glycosidase to milk. | 09-26-2013 |
Michael H Qvist, Fredenborg DK
Patent application number | Description | Published |
---|---|---|
20090010994 | Wound Dressing Comprising an Anti-Inflammatory Pain-Killing Agent and a Complex of Silver Ion and a Transitional Element of Group IV of the Periodic System of Elements - A wound dressing comprising one or more absorbent elements capable of absorbing wound exudates, a non-steroid anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group IV of the periodic system of elements. | 01-08-2009 |
20120189685 | WOUND DRESSING COMPRISING AN ANTI-INFLAMMATORY PAIN-KILLING AGENT AND A COMPLEX OF SILVER ION AND A TRANSITIONAL ELEMENT OF GROUP IV OF THE PERIODIC SYSTEM OF ELEMENTS - A wound dressing comprising one or more absorbent elements capable of absorbing wound exudates, a non-steroid anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group IV of the periodic system of elements. | 07-26-2012 |
Michael H. Qvist, Koebenhavn Oe DK
Patent application number | Description | Published |
---|---|---|
20080279842 | Controlled release dressing for enzymatic debridement of necrotic and non-viable tissue in a wound - A dressing for debridement of necrotic and non-viable tissue in a wound, wherein the dressing comprises an effective amount of one or more proteolytic enzymes incorporated in a degradable polymeric material. The dressing of the invention provides effective debridement of necrotic wounds over a prolonged period of time, as the enzymes may be released over time. As the enzymes are incorporated in the polymeric material, a high stability is achieved. | 11-13-2008 |
Per Qvist, Klampenborg DK
Patent application number | Description | Published |
---|---|---|
20090291462 | Detection or Quantification of Aggrecan and its Fragments - An immunoassay for aggrecan and/or aggrecan derived fragments comprises contacting a sample with an immunological binding partner which has specific binding affinity for the G2 domain of aggrecan at least when bearing keratan sulphate chains, and determining the existence or amount of specific binding of the immunological binding partner, which may be conducted as a sandwich assay using a first antibody that binds an N-terminal amino acid sequence comprising FFGVG . . . and a second antibody that binds an N-terminal amino acid sequence comprising ARGS. | 11-26-2009 |
20100317023 | BIOCHEMICAL MARKERS FOR CVD RISK ASSESSMENT - A method of diagnosis of cardiovascular disease (CVD) an immunoassay to measure aggrecan fragments in said sample, and association of an elevation above a normal level with the presence of CVD, is conducted by contacting aggrecan fragments in said sample with an first antibody reactive with an N-terminal first epitope formed by cleavage of aggrecan by a proteinase and with a second antibody reactive with a second aggrecan epitope which is present in aggrecan at a location in the C-terminal direction from the location of said N-terminal epitope, and measuring the extent of simultaneous binding of both antibodies. | 12-16-2010 |
20100323377 | BIOCHEMICAL MARKERS FOR CVD RISK ASSESSMENT - A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a protein of an atherosclerotic plaque such as lumican, versican, perlecan, decorin, biglycan, collagen type III, CRP, ApoE, or elastin, by a proteinase, said comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events. | 12-23-2010 |
20110244482 | ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II - A method of assay to determine the extent of collagen type II resorption activity comprising measuring the level of fragments of collagen type II that contain a cathepsin K generated neo-epitope not shared by collagen type I by binding the neo-epitope with an antibody specific for the neo-epitope and detecting the level of binding of said binding partner. | 10-06-2011 |
20110244483 | ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS - A method of assay measuring in a biological sample fragments of a protein that contain an N-terminal neo-epitope and a C-terminal neo-epitope, each generated by protease cleavage of said protein, comprises binding the N-terminal neo-epitope with a first specific antibody and binding the C-terminal neo-epitope with a second specific antibody, and detecting the extent of dual binding of said antibodies. | 10-06-2011 |
20110256639 | ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS - A method of immunoassay for fragments of a protein such as type II collagen in a biological sample detects fragments having a first epitope containing an isomerised amino acid residue and a second epitope generated by cleavage of the protein by the use of respective antibodies binding each of the two epitopes. | 10-20-2011 |
20130079295 | TREATMENT OF CARTILAGE RESORPTION - Excessive articular cartilage degradation is treated or prevented by administration to a mammal such as a human | 03-28-2013 |
Per Qvist, Aarhus C DK
Patent application number | Description | Published |
---|---|---|
20150245597 | HETEROZYGOUS MOUSE WITH AN INACTIVATED BRD1 ALLELE AND USES IN PSYCHIATRY - The present invention encompasses genetically modified non-human mammals comprising a genetic modification that inhibits and/or reduces BRD1 activity in one or more tissue or cell, methods of producing the same, methods and uses for identifying compounds for treating a mental disorder and pharmaceutical formulations of said compounds. | 09-03-2015 |
Troels Qvist, Borup DK
Patent application number | Description | Published |
---|---|---|
20100312321 | Embolization coil and delivery system - A detachable embolization coil is screw threaded at the proximal end for releasable attachment to a delivery member within a delivery catheter. The coil has a proximal fibred portion and a distal non-fibred portion, the axial length of the non-fibred portion being as great or greater than the axial length of the non-fibred portion. The fibred portion carries a plurality of fibres of thrombogenic fibrous material. In this way, a partially delivered coil may be retracted into a delivery catheter for repositioning, substantially without hindrance from clotting. | 12-09-2010 |
Troels Nicolaj Qvist, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20150209538 | LARYNGEAL MASK WITH A BITE ABSORBING CONNECTOR - A laryngeal mask insertable into a patient, an airway tube of the laryngeal mask having a bore extending from a proximal to a distal end of the airway tube, a connector provided at the proximal end of the airway tube, the connector comprising a connector body with a longitudinal bore, at least two wall portions extending longitudinally from a first continuous wall to a second continuous wall, and two parallel and opposite longitudinal wall cut-away portions intermediate the at least two wall portions, the length of the longitudinal wall cut-away portions being greater than the length of the first continuous wall. | 07-30-2015 |
Troels Nicolaj Qvist, Roskilde DE
Patent application number | Description | Published |
---|---|---|
20150246196 | LARYNGEAL MASK - A laryngeal mask for use in a patient comprises an airway tube having an inner lumen and a distal end; and a mask portion connected at a proximal end thereof to the distal end of the airway tube and having a distal tip opposite the proximal end. The mask portion comprises an inflatable cuff including an anterior cuff surface configured to contact the patient's tissue when the inflatable cuff is inflated; and a wedge portion including a stabilization surface and two walls connected to the inflatable cuff and extending therefrom toward from the stabilization surface, the stabilization surface extending from the distal tip of the mask portion toward the distal end of the airway tube at a wedge angle of between about 12 and 30 degrees, the wedge angle formed between the stabilization surface and the anterior cuff surface when the inflatable mask is inflated, whereby the stabilization surface is transversely and longitudinally substantially flat to stabilize the laryngeal mask in use. | 09-03-2015 |